jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 02] ubZ fnYyh] lkseokj] tuojh 1] 2018@ikS"k 11] 1939 No. 02] NEW DELHI, MONDAY, JANUARY 1, 2018/PAUSHA 11, 1939 jjjjllllkkkk;;;;uuuu vvvvkkkkSSjjSSjj mmmmooooZjZjZjZjdddd eeeea=a=a=a=kkkkyyyy;;;; ¼¼¼¼vvvvkkkk””SS””SSkkkk////kkkk ffffooooHHHHkkkkkkkkxxxx½½½½ ¼¼¼¼jjjjkkkk””””VVVVªªhhªªhh;;;; vvvvkkkk””SS””SSkkkk////kkkk eeeeYYwwYYww ;;;; ffffuuuu////kkkkkkkkZjZjZjZj....kkkk iiiizkzkzkzkffff////kkkkddddjjjj....kkkk½½½½ vvvvkkkknnnn’’ss’’ss kkkk ub Z fnYyh] 1 tuojh] 2018 ddddkkkk----vvvvkkkk---- 00002222¼¼¼¼vvvv½½½½.—Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½] rkjh[k 30 eb]Z 2013 vkSj dk-vk- 701¼v½] rkjh[k 10 ekp]Z 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk inz Rr 'kfDr;ks a dk i;z kxs djr s gq,] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldk s lfa{kIr :i e sa ,uihih, dgk tkrk gS½] uhp s dh lkj.kh d s LrHak ¼6½ e as fofufn"ZV [knq jk eYw ; dk s mDr lkj.kh d s LrHak ¼3½] ¼4½] vkSj ¼5½ e as rRLFkkuh ifzof"V;k sa e sa fofufn"ZV izcyrk] bdkb Z ¼;fwuV½ vkSj fofuekZrk vkSj foi.ku dEifu;ksa d s uke lfgr LrHak ¼2½ e sa dh rRLFkkuh ifzof"V e sa ls iRz;sd dh] oLr q ,o a lsok dj] ;fn dksbZ gS] dk s NksMd+ j vf/kdre [kqnjk eYw ; d s :i e sa fu;r djrh gAS llllkkkkjjjj....kkkkhhhh ØØØØzz--z--zllll--aa--aa vvvvuuuuqlqlqlqlffwwffwwpppprrrr ffffooooffffuuuuffffeeeeffZZffZZrrrr ddddkkkk iiiicczzcczz yyyyrrrrkkkk bbbbddddkkkkbbbb ZZ ZZ ffffooooffffuuuueeeekkkkZrZrZrZrkkkk vvvvkkkkSSjjSjSj ffffooooiiii....kkkkuuuu ddddiiaaiiaa uuuuhhhh [[[[kkkknnqqnnqq jjjjkkkk eeeeYYwwYYww ;;;; uuuukkkkeeee@@@@cccczkzkzkzkMMaaMMaa ddddkkkk uuuukkkkeeee ¼¼¼¼####----½½½½ ¼¼¼¼1111½½½½ ¼¼¼¼2222½½½½ ¼¼¼¼3333½½½½ ¼¼¼¼4444½½½½ ¼¼¼¼5555½½½½ ¼¼¼¼6666½½½½ 1. fdYuhMkbfiu $ feVkis zkys kys iRz;ds fQYe fyfir ck;y;s M Z xkys h e:sa 1 xkys h eSll Z I;ksj ,Ma D;ksj 7.346 xkys h fdYuhMkbfiu 10 fexzk-] feVkis zksykys gYs Fkd;s j izkboVs fyfeVMs @ lqlhusV vkbiZ h 47-5 fexzk- d s cjkcj eSll Z buVkl QkekZL;fwVdYl feVkis zkys kys VkjVªVs 50 fexzk- ¼bvZ kj½ izk- fy- 2. eVs QkfseZu $ fXyefsijkbM $ iRz;ds xkys h es%a 1 xkys h eSll Z luXyk s QkekZL;fwVdYl 8.17 okXsyhckWl xkys h eVs QkfseZu ,plh,y 500 fexzk- ¼lLVMsa izk- fy-@eSll Z buVkl jhfyt Qkes Z esa½] fXyefsijkbM 1 fexzk-] QkekZL;fwVdYl fy- okXsyhckWl 0-3 fexzk- 04 GI/2018 (1) 2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 3. jkslwoklVkfVu $ DyksfiMkxs yzs iRz;ds gkM Z tys fsVu dISlwy e%sa 1 dISlyw eSll Z lkbukds es 7.80 dISlyw jkts qoklVkfVu dSfY’k;e vkbiZ h d s QkekZL;fwVdYl fy-@eSll Z cjkcj jkts qoklVkfVu 20 fexzk-] dfSMyk QkekZL;fwVdYl fy- DykfsiMkxs yzs ckblYQsV ds cjkcj DykfsiMkxs yzs 75 fexzk- 4. Vys felkjVu $ DyksjFkkfyMkWu iRz;ds fQYe vfyfir xkys h e%sa 1 xkys h eSll Z lu Qkek Z ycs ksjsVkfsjt 6.713 xkys h ¼fVxkVsy lh,p 80½ Vys felkjVu vkbiZ h 80 fexzk-] fy- DyksjFkkfyMkWu vkbiZ h 12-5 fexzk- 5. jkts qoklVkfVu $ DykfsiMkxs yzs iRz;ds gkM Z tys fsVu dISlwy e%sa 1 dISlyw eSll Z lkbukds es 7.80 dISlyw jkts qoklVkfVu dSfY’k;e vkbiZ h d s QkekZL;fwVdYl fy-@eSll Z cjkcj jkts qoklVkfVu 20 fexzk- ¼IysVl tk;Ml fy- e½sa] DykfsiMkxs yzs fclYQsV vkbiZ h d s cjkcj DykfsiMkxs yzs 75 fexzk- ¼fiySVl esa½ 6. iSjkflVkekys $ dfSQu iRz;ds vfyfir xkys h e%sa iSjkflVkekys 1 xkys h eSll Z MYs l ycs ksjsVksfjt fy- 2.57 $MkbQZ fsuMªkekbu ,plh,y vkbiZ h 500 fexzk-] dfSQu ¼,ugkbMªl½- eys h,V $ QsuhysÝhu 30 fexzk] MkbQZ fsuMªkekbu ,plh,y 25 gkbMªkDs yksjkbM xkys h fexzk-] QsuhyÝs hu gkbMªkDs yksjkbM vkbiZ h ¼lkbul 77½ 5 fexzk- 7. ,VksjoklVkfVu $ iRz;ds gkM Z tys fsVu dISlwy e%sa 1 eSll Z lk;ukds es 8.394 DykfsiMkxs yzs dSIlyw ,VksjoklVkfVu dfSY’k;e vkbiZ h d s dISlyw QkekZL;fwVdYl fy-@eSll Z cjkcj ,VksjoklVkfVu 10 fexzk-] bfjl ykbQZ lkbalsl fy- DykfsiMkxs yzs ckblYQsV vkbiZ h d s cjkcj DykfsiMkxs yzs 75 fexzk- 8. ,VksjoklVkfVu $ iRz;ds gkM Z tys fsVu dISlwy e%sa 1 eSll Z lk;ukds es 10.596 DykfsiMkxs yzs dSIlyw ,VksjoklVkfVu dfSY’k;e vkbiZ h d s dISlyw QkekZL;fwVdYl fy-@eSll Z cjkcj ,VksjoklVkfVu 20 fexzk-] ,fjl ykbQZ lkbalsl DykfsiMkxs yzs ckblYQsV vkbiZ h d s fy- cjkcj DykfsiMkxs yzs 75 fexzk- 9. fXyDyktkbM $ esVQkfseZu iRz;ds vfyfir xkys h e:sa 1 xkys h eSll Z ,dEl MªXl ,Ma 4.354 xkys h ¼Xykbpds ,e $½ fXyDyktkbM vkbiZ h 40 fexzk-] QkekZL;fwVdYl fy-@eSll Z eVs QkfseZu gkbMªkDs yksjkbM 500 fexzk- buMkds k s jsfeMht fy- 10. ,VksjoklVkfVu $ iRz;ds gkM Z tys fsVu dISlwy e%sa 1 eSll Z foMa ykl ck;ksVds izk- 10.596 DykfsiMkxs yzs dSIlyw ¼,Vkds ksj ,VksjoklVkfVu dfSY’k;e vkbiZ h d s dISlyw fy-@eSll Z MkW- jMs M~ ht lhoh 20 fexzk-½ cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;ds ycs ksjVs kfsjt fy- nk s fQYe fyfir xkys h e sa ,VksjoklVkfVu 10 fexzk-½] DykfsiMkxs yzs ckblYQVs vkbiZ h d s cjkcj DykfsiMkxs yzs 75 fexzk- ¼iRz;ds nk s fQYe fyfir xkys h e sa 37-5 fexzk-½] 11. ,VksjoklVkfVu $ iRz;ds dSIlyw esa% 1 eSll Z ekbØk s ycs - fy- 10.596 DykfsiMkxs yzs dSIlyw ¼,okl ,VksjoklVkfVu dfSY’k;e vkbiZ h d s dISlyw 20 xkYs M½ cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;ds fQYe fyfir xkys h esa½] DyksfiMksxyzs ckblYQVs vkbiZ h ds cjkcj DykfsiMkxs yzs 75 fexzk- ¼izR;ds nk s fQYe fyfir xkys h e sa 37-5 fexzk-½] 12. ,VksjoklVkfVu $ iRz;ds dSIlyw esa% 1 eSll Z ekbØk s ycs - fy- 10.596 DykfsiMkxs yzs dSIlyw ,VksjoklVkfVu dfSY’k;e vkbiZ h d s dISlyw ¼,lfVu 20 xkYs M½ cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;ds fQYe fyfir xkys h e½sa] DykfsiMkxs yzs ckblYQsV vkbiZ h d s cjkcj DykfsiMkxs yzs 75 fexzk- ¼iRz;ds nks fQYe fyfir xkys h e sa 37-5 fexzk-½] ¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 13. jkts qoklVkfVu$ DykfsiMkxs yzs iRz;ds gkM Z tsyfsVu dISlyw es%a 1 dISlyw eSll Z lkbukds es 13.37 dISlyw QkekZL;fwVdYl fy-@eSll Z jkts qoklVkfVu dSfY’k;e vkbiZ h d s bfjl ykbQZ lkbfalt fy- cjkcj jkts qoklVkfVu 10 fexzk-] DykfsiMkxs yzs ckblYQsV ds cjkcj DykfsiMkxs yzs 75 fexzk- 14. jkts qoklVkfVu$DykfsiMkxs yzs iRz;ds gkM Z tsyfsVu dISlyw es%a 1 dISlyw eSll Z lkbukds es 7.80 dISlyw QkekZL;fwVdYl fy-@eSll Z jkts qoklVkfVu dSfY’k;e vkbiZ h d s ,fjl ykbQZ lkbfalt fy- cjkcj jkts qoklVkfVu 20 fexzk-] DykfsiMkxs yzs ckblYQVs d s cjkcj DykfsiMkxs yzs 75 fexzk- uuuukkkkVVssVVss %%%% ¼d½ mi;qZDr nh xb Z fofufn"ZV QkWeywZ s'ku d s fofuekZrk vFkkZr tk s Þub Z Mªxß Mhihlhvk]s 2013 d s iSjkxzkQ 2¼;½w d s rgr mi;qZDr nh xb Z lkj.kh d s LrHak ¼6½ e sa fofufn"ZV [knq jk eYw ; fu/kkfZjr djxsa As ¼[k½ vxj fuekZrkvks a u s mi;qZDr lkj.kh d s LrHak ¼6½ esa of.kZr vf/kdre dher ij ljdkj dks okLro e sa Hkqxrku fd;k gS ;k ;g n;s gS rk s o s oLr q ,o a lsok dj dk s tkMs + ldr s gSAa ¼x½ vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 11 e sa fn, x, izko/kkuk sa d s rgr fuekZrkvk sa dk s mi;qDZ r lkj.kh d s LrHak ¼6½ e sa fofufn"ZV [knq jk eYw ; d s vk/kkj ij vuqlfwpr fofufefZr;k sa d s iSdksa d s fy, [knq jk eYw ; fu/kkfZjr djsaA fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 24 d s rgr QkWe Z V e sa vf/klpw uk dh rkjh[k l s ,d eYw ; lpw h ,uihih, dk s vkbZihMh,e,l d s ek/;e l s tkjh djAsa ¼?k½ vkS"k/k ¼eYw ; fu;a=.k½ vkns'k] 2013 d s 24 ¼4½ d s mic/akk sa d s vuqlkj iRz;ds QVq dj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sl s ifjlj] tgk a dkjckj dk s bl idz kj fd;k tk jgk gS fd mll s ijke’kZ d s bPNdq fdlh O;fDr d s fy, igpqa vklku gk]s ogk a mld s fdlh lgtn’` ; Hkkx ij dher lpw h vkSj iwjd lpw h] ;fn dkbs Z gk]s dk s lainz f’kZr djxs kA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[knq jk eYw ;½ dsoy mi;qZDr [email protected] d s fy, ykx w gS tSlk fd mUgkusa s vkS"k/k ¼eYw ; fu;a=.k½ vkn's k] 2013 d s rgr vuqc) eYw ; fu/kkZj.k@la'kk/sku d s fy, QkWe Z I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkfZjr lHkh ykxw oS/kkfud vko';drkvk sa dh ifwr Z d s v/khu izklfaxd fof/k;ksa@fu;ek sa d s vUrxZr tSlk fd dUsnzh;@jkT; ykblfslxa vkWFkkfsjVh d s l{ke izkf/kdkjh }kjk eUs;wQsDpfjxa ykblsal eta wjh d s rgr lca fa/kr fofufeZr [email protected] dEifu;k a tk s vuqikyu djrh gSA ¼p½ mi;qZDr fofufefZr;k sa dh mRiknu@vk;kr vkSj fcØh d s lEcU/k e sa lEcfU/kr fuekZrkvk sa dk s vkS"k/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s vuqlpw h II d s QkWe Z III dk s vkbZihMh,e,l d s ek/;e l s Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr djxs kA mi;qZDr fofufefZr;ksa d s fuek.Z k dk s dksbZ fuekZrk mRiknu cUn djus dk bPNdq gks rks bldh lpw uk ,uihih, dks voxr djk;xs kA bld s lEcU/k e sa vxj fofufefZr;ksa d s mRiknu vkSj vk;kr dk s cUn djus dk bPNdq gS rk s cUn djus dh frfFk l s de l s de N% eghu s igy s lpw h II d s QkWe Z IV e sa Hkjdj ,uihih, dk s izLrqr djxs kA ¼N½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufefZr;k sa vkSj fofufn"ZV 'krks± dk ikyu ugh a djrh gS a rk s o s vko';d oLrq,¡ vf/kfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk sa d s v/khu C;kt lfgr vf/kiHzkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxsa As ¼t½ bl vkn's k e sa mijkDs r lkj.kh d s LrHak ¼2½ e sa dh rRLFkkuh ifzof"V e sa fofufn"ZV fofufefZr;k sa d s iSdk sa dh [knq jk eYw ; fu;r gkus s d s ifj.kkeLo#i] vkn's k tk s fd bl vkn's k l s iow Z tkjh gq, gS] Lor% gh fujLr gk s tk;xsa As [dk-a l-a@184@52@2017@,Q@Qk- l-a 8¼52½@2017@Mhih@,uihih,&fMoh- II] cythr flag]]]] lgk;d funs'kd 4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 1st January, 2018 S.O. 02(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE Sl. Name of the Strength Unit Manufacturer & Retail No. Scheduled Marketing Company Price (Rs.) Formulation/Brand Name 1. Cilnidipine + Each film coated Bi- Layered tablet 1 Tablet M/s. Pure and Cure 7.346 Metoprolol Tablet contains: Healthcare Pvt Ltd. / Cilnidipine 10mg, M/s Intas Metoprolol Succinate IP 47.5mg eq. Pharmaceuticals Pvt. to Metoprolol Tartrate 50mg (ER) Ltd. 2. Metformin + Each tablet contains: 1 Tablet M/s. Sunglow 8.17 Glimepiride + Metformin HCL 500mg Pharmaceuticals Pvt. Voglibose Tablets (as sustained release form) Ltd. / M/s Intas Glimepiride 1mg Pharmaceuticals Ltd. Voglibose 0.3mg 3. Rosuvastatin + Each Hard gelatin capsule contains: 1 Capsule M/s. Synokem 7.80 Clopidogrel Capsule Rosuvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Rosuvastatin 20mg, M/s Cadila Clopidogrel Bisulphate IP eq. to Pharmaceuticals Ltd. Clopidogrel 75mg 4. Telmisartan + Each film coated tablet contains: 1 Tablet M/s. Sun Pharma 6.713 Chlorthalidone Tablet Telmisartan IP 80mg, Laboratories Limited (Tigatel CH 80) Chlorthalidone IP 12.5mg 5. Rosuvastatin + Each hard gelatin capsule contains: 1 Capsule M/s. Synokem 7.80 Clopidogrel Capsule Rosuvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Rosuvastatin 20mg (As pellets) M/s Zydus Healthcare Clopidogrel Bisulphate IP eq. to Ltd. Clopidogrel 75mg (As pellets) 6. Paracetamol+Caffeine+ Each uncoated tablet contains: 1 Tablet M/s. Dales 2.57 Phenylephrine+ Paracetamol-500mg Laboratories Pvt. Ltd. Diphenhydramine Caffeine (anhydrous)-30mg Tablet (Sinus77) Phenylephrine HCl-5mg Diphenhydramine HCl-25mg 7. Atorvastatin + Each hard gelatin capsule contains: 1 Capsule M/s. Synokem 8.394 Clopidogrel Capsule Atorvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Atorvastatin 10mg, M/s Eris Lifesciences Clopidogrel Bisulphate IP eq. to Limited Clopidogrel 75mg 8. Atorvastatin + Each hard gelatin capsule contains: 1 Capsule M/s. Synokem 10.596 Clopidogrel Capsule Atorvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Atorvastatin 20mg, M/s Eris Lifesciences Clopidogrel Bisulphate IP eq. to Limited Clopidogrel 75mg ¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5 9. Gliclazide + Each uncoted tablet contains: 1 Tablet M/s. Akums Drugs & 4.354 Metformin Tablet Gliclazide IP 40mg, Pharmaceuticals Ltd. / (Glychek M +) Metformin Hydrochloride IP M/s Indoco Remedies 500mg Limited 10. Atorvastatin + Each hard gelatin capsule contains: 1 Capsule M/s. Windlas Biotech 10.596 Clopidogrel Capsule Atorvastatin Calcium IP eq. to Pvt. Ltd. / M/s Dr. (Atocor CV 20mg) Atorvastatin 20mg (As two film Reddy’s Laboratories coated tablet Each containing Ltd. Atorvastatin 10mg) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) 11. Atorvastatin + Each capsule contains: 1 Capsule M/s Micro Lab. Ltd. 10.596 Clopidogrel Capsule Atorvastatin Calcium IP eq. to (Avas 20 Gold) Atorvastatin 20mg (As film coated tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) 12. Atorvastatin + Each capsule contains: 1 Capsule M/s Micro Lab. Ltd. 10.596 Clopidogrel Capsule Atorvastatin Calcium IP eq. to (Astin 20 Gold) Atorvastatin 20mg (As film coated tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) 13. Rosuvastatin + Each hard gelatin capsule contains: 1 Capsule M/s Synokem 13.37 Clopidogrel Capsule Rosuvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Rosuvastatin 10mg, M/s Eris Lifesciences Clopidogrel Bisulphate IP eq. to Limited Clopidogrel 75mg 14. Rosuvastatin + Each hard gelatin capsule contains: 1 Capsule M/s Synokem 7.80 Clopidogrel Capsule Rosuvastatin Calcium IP eq. to Pharmaceuticals Ltd. / Rosuvastatin 20mg, M/s Eris Lifesciences Clopidogrel Bisulphate IP eq. to Limited Clopidogrel 75mg Note: (a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer/marketeer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/ revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. 6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (f) The concerned manufacturer of above said formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of product in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Manufacturer, in case intending to discontinue above said formulations, shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (g) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/184/52/2017/F/F. No. 8(52)/2017/D.P./NPPA-Div.-II] BALJIT SINGH, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.